Maryland 2025 Regular Session

Maryland House Bill HB553 Compare Versions

OldNewDifferences
11
22
33 EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW.
44 [Brackets] indicate matter deleted from existing law.
5- Underlining indicates amendments to bill.
6- Strike out indicates matter stricken from the bill by amendment or deleted from the law by
7-amendment.
85 *hb0553*
96
107 HOUSE BILL 553
118 J1 5lr3326
129 CF SB 94
1310 By: Delegates Taveras, Boafo, Harrison, Holmes, Lehman, Terrasa, and Vogel
14-Vogel, Pena–Melnyk, Cullison, Alston, Bagnall, Bhandari, Guzzone, Hill,
15-Hutchinson, S. Johnson, Kaiser, Kerr, Lopez, Martinez, Rosenberg,
16-White Holland, Woods, and Woorman
1711 Introduced and read first time: January 22, 2025
1812 Assigned to: Health and Government Operations
19-Committee Report: Favorable with amendments
20-House action: Adopted
21-Read second time: February 22, 2025
2213
23-CHAPTER ______
14+A BILL ENTITLED
2415
2516 AN ACT concerning 1
2617
27-Maryland Medical Assistance Program – Maternal Health Self–Measured Blood 2
28-Pressure Monitoring 3
18+Maryland Medical Assistance Program – Self–Measured Blood Pressure 2
19+Monitoring 3
2920
3021 FOR the purpose of requiring, beginning on a certain date, the Maryland Medical 4
3122 Assistance Program to provide coverage for self–measured blood pressure 5
3223 monitoring for certain eligible Program recipients; requiring the Program to develop 6
3324 and implement a certain education campaign; and generally relating to 7
3425 self–measured blood pressure monitoring under the Maryland Medical Assistance 8
3526 Program. 9
3627
3728 BY repealing and reenacting, without amendments, 10
3829 Article – Health – General 11
3930 Section 15–101(h), (j), and (l) and 15–103(a)(1) 12
4031 Annotated Code of Maryland 13
4132 (2023 Replacement Volume and 2024 Supplement) 14
4233
4334 BY repealing and reenacting, with amendments, 15
4435 Article – Health – General 16
4536 Section 15–103(a)(2)(xxiii) and (xxiv) 17
4637 Annotated Code of Maryland 18
4738 (2023 Replacement Volume and 2024 Supplement) 19
39+
40+BY adding to 20
41+ Article – Health – General 21
42+Section 15–103(a)(2)(xxv) and 15–141.6 22
43+ Annotated Code of Maryland 23
44+ (2023 Replacement Volume and 2024 Supplement) 24
45+
46+ SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 25
47+That the Laws of Maryland read as follows: 26
4848 2 HOUSE BILL 553
4949
5050
51-BY adding to 1
52- Article – Health – General 2
53-Section 15–103(a)(2)(xxv) and 15–141.6 3
54- Annotated Code of Maryland 4
55- (2023 Replacement Volume and 2024 Supplement) 5
51+Article – Health – General 1
5652
57- SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 6
58-That the Laws of Maryland read as follows: 7
53+15–101. 2
5954
60-Article – Health – General 8
55+ (h) “Program” means the Maryland Medical Assistance Program. 3
6156
62-15–101. 9
57+ (j) “Self–measured blood pressure monitoring” means the regular measurement 4
58+of blood pressure by the patient outside the clinical setting, either at home or elsewhere, 5
59+requiring the use of a home blood pressure measurement device by the patient. 6
6360
64- (h) “Program” means the Maryland Medical Assistance Program. 10
61+ (l) “Validated home blood pressure monitor” means a blood pressure 7
62+measurement device that has been validated for accuracy and is listed in the U.S. Blood 8
63+Pressure Validated Device Listing. 9
6564
66- (j) “Self–measured blood pressure monitoring” means the regular measurement 11
67-of blood pressure by the patient outside the clinical setting, either at home or elsewhere, 12
68-requiring the use of a home blood pressure measurement device by the patient. 13
65+15–103. 10
6966
70- (l) “Validated home blood pressure monitor” means a blood pressure 14
71-measurement device that has been validated for accuracy and is listed in the U.S. Blood 15
72-Pressure Validated Device Listing. 16
67+ (a) (1) The Secretary shall administer the Maryland Medical Assistance 11
68+Program. 12
7369
74-15–103. 17
70+ (2) The Program: 13
7571
76- (a) (1) The Secretary shall administer the Maryland Medical Assistance 18
77-Program. 19
72+ (xxiii) Beginning on July 1, 2025, shall provide, subject to the 14
73+limitations of the State budget, and as permitted by federal law, coverage for biomarker 15
74+testing in accordance with § 15–859 of the Insurance Article; [and] 16
7875
79- (2) The Program: 20
76+ (xxiv) Beginning on January 1, 2025, shall provide coverage for 17
77+prostheses in accordance with § 15–844 of the Insurance Article; AND 18
8078
81- (xxiii) Beginning on July 1, 2025, shall provide, subject to the 21
82-limitations of the State budget, and as permitted by federal law, coverage for biomarker 22
83-testing in accordance with § 15–859 of the Insurance Article; [and] 23
79+ (XXV) BEGINNING ON JANUARY 1, 2026, SHALL PROVIDE , 19
80+SUBJECT TO THE LIMITAT IONS OF THE STATE BUDGET , AND AS PERMITTED BY 20
81+FEDERAL LAW , COVERAGE FOR SELF –MEASURED BLOOD PRESS URE MONITORING 21
82+FOR ELIGIBLE PROGRAM RECIPIENTS IN ACCORDANCE WITH § 15–141.6 OF THIS 22
83+SUBTITLE. 23
8484
85- (xxiv) Beginning on January 1, 2025, shall provide coverage for 24
86-prostheses in accordance with § 15–844 of the Insurance Article; AND 25
85+15–141.6. 24
8786
88- (XXV) BEGINNING ON JANUARY 1, 2026, SHALL PROVIDE , 26
89-SUBJECT TO THE LIMIT ATIONS OF THE STATE BUDGET , AND AS PERMITTED BY 27
90-FEDERAL LAW , COVERAGE FOR SELF –MEASURED BLOOD PRESS URE MONITORING 28
91-FOR ELIGIBLE PROGRAM RECIPIENTS IN ACCORDANCE WITH § 15–141.6 OF THIS 29
92-SUBTITLE. 30
87+ (A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS 25
88+INDICATED. 26
9389
94-15–141.6. 31
95- HOUSE BILL 553 3
90+ (2) “ELIGIBLE PROGRAM RECIPIENT ” MEANS A PROGRAM 27
91+RECIPIENT WHO : 28
9692
93+ (I) IS PREGNANT; 29
9794
98- (A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS 1
99-INDICATED. 2
100-
101- (2) “ELIGIBLE PROGRAM, “ELIGIBLE PROGRAM RECIPIENT” MEANS 3
102-A PROGRAM RECIPIENT WHO : 4
103-
104- (I) (1) IS PREGNANT; 5
105-
106- (II) (2) IS POSTPARTUM ; OR 6
107-
108- (III) (3) HAS BEEN DIAGNOSED WITH : 7
109-
110- 1. (I) CHRONIC KIDNEY DISEAS E; 8
111-
112- 2. (II) DIABETES; 9
113-
114- 3. (III) HEART DISEASE; OR 10
115-
116- 4. (IV) A CARDIOMETABOLIC DISE ASE. 11
117-
118- (3) “HEALTH CARE PROVIDER ” MEANS: 12
119-
120- (I) A PERSON WHO IS LICENS ED, CERTIFIED, OR OTHERWISE 13
121-AUTHORIZED UNDER THE HEALTH OCCUPATIONS ARTICLE TO PROVIDE HE ALTH 14
122-CARE IN THE ORDINARY COURSE OF BUSINESS O R PRACTICE OF A PROF ESSION, OR 15
123-IN AN APPROVED EDUCA TION OR TRAINING PRO GRAM; OR 16
124-
125- (II) A COMMUNITY HEALTH WOR KER CERTIFIED UNDER TITLE 17
126-13, SUBTITLE 37 OF THIS ARTICLE. 18
127-
128- (B) THE PROGRAM SHALL PROVIDE COVERAGE FOR SELF –MEASURED 19
129-BLOOD PRESSURE MONIT ORING FOR ALL ELIGIB LE PROGRAM RECIPIENTS , 20
130-INCLUDING: 21
131-
132- (1) THE PROVISION OF VALI DATED HOME BLOOD PRE SSURE 22
133-MONITORS; AND 23
134-
135- (2) REIMBURSEMENT OF HEAL TH CARE PROVIDER AND OTHER STAFF 24
136-TIME USED FOR PATIEN T TRAINING, TRANSMISSION OF BLOO D PRESSURE DATA , 25
137-INTERPRETATION OF BL OOD PRESSURE READING S AND REPORTING , REMOTE 26
138-PATIENT MONITORING , AND THE DELIVERY OF CO–INTERVENTIONS , INCLUDING 27
139-EDUCATIONAL MATERIAL S OR CLASSES. 28
140- 4 HOUSE BILL 553
141-
142-
143- (C) THE PROGRAM SHALL DEVELOP AND IMPLEMENT AN EDU CATION 1
144-CAMPAIGN TO INFORM E LIGIBLE PROGRAM RECIPIENTS AN D HEALTH CARE 2
145-PROVIDERS ABOUT THE BENEFITS AND USAGE O F BLOOD PRESSURE MON ITORING 3
146-TECHNOLOGY AND THE A VAILABILITY OF ASSIS TANCE WITH SETUP AND 4
147-TROUBLESHO OTING. 5
148-
149- (D) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2027, THE 6
150-DEPARTMENT SHALL SUBM IT A REPORT TO THE SENATE FINANCE COMMITTEE AND 7
151-THE HOUSE HEALTH AND GOVERNMENT OPERATIONS COMMITTEE, IN 8
152-ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT ARTICLE, THAT 9
153-INCLUDES: 10
154-
155- (1) THE TOTAL NUMBER OF E LIGIBLE PROGRAM RECIPIENTS WH O 11
156-RECEIVED BLOOD PRESS URE MONITORS UNDER T HIS SECTION DURING T HE 12
157-IMMEDIATELY PRECEDIN G 12–MONTH PERIOD ; 13
158-
159- (2) THE OUTCOMES ASSOCIAT ED WITH THE USE OF T HE HOME BLOOD 14
160-PRESSURE MONITORS UNDER THIS SECTION ; AND 15
161-
162- (3) ANY COST SAVINGS ACHI EVED BY THE PROGRAM DURING THE 16
163-IMMEDIATELY PRECEDIN G FISCAL YEAR ASSOCI ATED WITH THE USE OF THE HOME 17
164-BLOOD PRESSURE MONIT ORS DISTRIBUTED IN A CCORDANCE WITH THIS SECTION. 18
165-
166- SECTION 2. AND BE IT FURTHER ENA CTED, That this Act shall take effect July 19
167-1, 2025. 20
95+ (II) IS POSTPARTUM ; OR 30 HOUSE BILL 553 3
16896
16997
17098
99+ (III) HAS BEEN DIAGNOSED WI TH: 1
100+
101+ 1. CHRONIC KIDNEY DISEAS E; 2
102+
103+ 2. DIABETES; 3
104+
105+ 3. HEART DISEASE; OR 4
106+
107+ 4. A CARDIOMETABOLIC DISE ASE. 5
108+
109+ (3) “HEALTH CARE PROVIDER ” MEANS: 6
110+
111+ (I) A PERSON WHO IS LICENS ED, CERTIFIED, OR OTHERWISE 7
112+AUTHORIZED UNDER THE HEALTH OCCUPATIONS ARTICLE TO PROVIDE HE ALTH 8
113+CARE IN THE ORDINARY COURSE OF BUSINESS O R PRACTICE OF A PROFES SION, OR 9
114+IN AN APPROVED EDUCA TION OR TRAINING PRO GRAM; OR 10
115+
116+ (II) A COMMUNITY HEALTH WOR KER CERTIFIED UNDER TITLE 11
117+13, SUBTITLE 37 OF THIS ARTICLE. 12
118+
119+ (B) THE PROGRAM SHALL PROVIDE COVERAGE FOR SELF –MEASURED 13
120+BLOOD PRESSURE MONIT ORING FO R ALL ELIGIBLE PROGRAM RECIPIENTS , 14
121+INCLUDING: 15
122+
123+ (1) THE PROVISION OF VALI DATED HOME BLOOD PRE SSURE 16
124+MONITORS; AND 17
125+
126+ (2) REIMBURSEMENT OF HEAL TH CARE PROVIDER AND OTHER STAFF 18
127+TIME USED FOR PATIEN T TRAINING, TRANSMISSION OF BLOO D PRESSURE DATA , 19
128+INTERPRETATI ON OF BLOOD PRESSURE READINGS AND REPORTI NG, REMOTE 20
129+PATIENT MONITORING , AND THE DELIVERY OF CO–INTERVENTIONS , INCLUDING 21
130+EDUCATIONAL MATERIAL S OR CLASSES. 22
131+
132+ (C) THE PROGRAM SHALL DEVELOP AND IM PLEMENT AN EDUCATION 23
133+CAMPAIGN TO INFORM E LIGIBLE PROGRAM RECIPIE NTS AND HEALTH CARE 24
134+PROVIDERS ABOUT THE BENEFITS AND USAGE O F BLOOD PRESSURE MON ITORING 25
135+TECHNOLOGY AND THE A VAILABILITY OF ASSIS TANCE WITH SETUP AND 26
136+TROUBLESHOOTING . 27
137+
138+ (D) ON OR BEFORE DECEMBER 1 EACH YEAR, BEGINNING IN 2027, THE 28
139+DEPARTMENT SHALL SUBM IT A REPORT TO THE SENATE FINANCE COMMITTEE AND 29
140+THE HOUSE HEALTH AND GOVERNMENT OPERATIONS COMMITTEE, IN 30 4 HOUSE BILL 553
171141
172142
173-Approved:
174-________________________________________________________________________________
175- Governor.
176-________________________________________________________________________________
177- Speaker of the House of Delegates.
178-________________________________________________________________________________
179- President of the Senate.
143+ACCORDANCE WITH § 2–1257 OF THE STATE GOVERNMENT ARTICLE, THAT 1
144+INCLUDES: 2
145+
146+ (1) THE TOTAL NUMBER OF E LIGIBLE PROGRAM RECIPIENTS WH O 3
147+RECEIVED BLOOD PRESS URE MONITORS UNDER THIS SECTION DURING THE 4
148+IMMEDIATELY PRECEDIN G 12–MONTH PERIOD ; 5
149+
150+ (2) THE OUTCOMES ASSOCIAT ED WITH THE USE OF T HE HOME BLOOD 6
151+PRESSURE MONITORS UN DER THIS SECTION ; AND 7
152+
153+ (3) ANY COST SAVINGS ACHI EVED BY THE PROGRAM DURING THE 8
154+IMMEDIATELY PRECEDING FISCAL YEA R ASSOCIATED WITH TH E USE OF THE HOME 9
155+BLOOD PRESSURE MONIT ORS DISTRIBUTED IN A CCORDANCE WITH THIS SECTION. 10
156+
157+ SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect July 11
158+1, 2025. 12
159+